Literature DB >> 6429046

Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice.

G C Tsay, M S Collins.   

Abstract

Acid treatment of Pseudomonas aeruginosa immunotype 1 lipopolysaccharide generated a low-molecular-weight polysaccharide fraction that was detectable in agar gel immunodiffusion but did not induce antibodies or resistance to infection in mice. The polysaccharide was treated with periodate to generate additional aldehyde groups. Oxidized polysaccharide was covalently coupled by reductive amination to 1,4-diaminobutyl-derivatized bovine serum albumin. Physical properties of the conjugate were characterized by gel filtration and high-pressure liquid chromatography. The gelation activity of the conjugate in the Limulus amoebocyte lysate assay was 4,000-fold less than native lipopolysaccharide by weight. Mice immunized with the conjugate resisted challenge with P. aeruginosa immunotype 1 that killed 90% of mice immunized with saline. Immunization with the conjugate vaccine induced humoral immunoglobulin G that passively protected normal and burned mice. These results indicate that conjugation of nonimmunogenic polysaccharide antigen of P. aeruginosa restores immunogenicity similar to that of native lipopolysaccharide without restoring endotoxicity inherent in lipopolysaccharide.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429046      PMCID: PMC263303          DOI: 10.1128/iai.45.1.217-221.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Nonspecificity of the limulus amebocyte lysate test: positive reactions with polynucleotides and proteins.

Authors:  R J Elin; S M Wolff
Journal:  J Infect Dis       Date:  1973-09       Impact factor: 5.226

2.  A simple method for coupling proteins to insoluble polysaccharides.

Authors:  C J Sanderson; D V Wilson
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

3.  Modified diphenylamine reaction for increased sensitivity.

Authors:  G N Abraham; C Scaletta; J H Vaughan
Journal:  Anal Biochem       Date:  1972-10       Impact factor: 3.365

4.  New immunotype schema for Pseudomonas aeruginosa based on protective antigens.

Authors:  M W Fisher; H B Devlin; F J Gnabasik
Journal:  J Bacteriol       Date:  1969-05       Impact factor: 3.490

5.  Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G.

Authors:  E Engvall; P Perlmann
Journal:  Immunochemistry       Date:  1971-09

6.  Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides.

Authors:  E Kaiser; R L Colescott; C D Bossinger; P I Cook
Journal:  Anal Biochem       Date:  1970-04       Impact factor: 3.365

7.  Pseudomonas aeruginosa vaccine in cancer patients.

Authors:  L S Young; R D Meyer; D Armstrong
Journal:  Ann Intern Med       Date:  1973-10       Impact factor: 25.391

8.  Significance of Pseudomonas aeruginosa in the patient with leukemia or lymphoma.

Authors:  S C Schimpff; W H Greene; V M Young; P H Wiernik
Journal:  J Infect Dis       Date:  1974-11       Impact factor: 5.226

9.  Contribution of humoral and cellular factors to the resistance to experimental infection by Pseudomonas aeruginosa in mice. I. Interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria.

Authors:  A B Bjornson; J G Michael
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

10.  Investigations on the specificity of the Limulus test for the detection of endotoxin.

Authors:  A Wildfeuer; B Heymer; K H Schleifer; O Haferkamp
Journal:  Appl Microbiol       Date:  1974-11
View more
  2 in total

1.  Pseudomonas aeruginosa immunotype 5 polysaccharide-toxin A conjugate vaccine.

Authors:  S J Cryz; E Furer; J C Sadoff; R Germanier
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

2.  Coprecipitation of lipopolysaccharide and the 39,000-molecular-weight major outer membrane protein of Haemophilus influenzae type b by lipopolysaccharide-directed monoclonal antibody.

Authors:  P A Gulig; E J Hansen
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.